ARCHIVES

Phase III Trial Would Give Clearer Picture Of C225 Role.

This article is from The Cancer Letter archive.

Vol. 28 No. 07 | February 15, 2002

Download PDF Visit The Full Archive

Related Articles

Group Chairmen Reject DCT’s Agenda For Clinical Trials Review, demand Right To Select Speakers

June 30, 1978

NCI New Advisory Group Named On special Populations

June 25, 1999

Survival For ALL Increased To 94 Percent In Recent Years

December 31, 2010

Study: Drug Discounts Used For Wealthier Patients In Many 340B-Enrolled Hospitals

October 10, 2014

Individualized Cancer Vaccines Show 90% Survival at 6 Months

December 27, 2013

NCI To Offer Advice On Unconventional Therapy. Not Funds

December 14, 1990